Indacaterol and Mometasone

Therapeutic indications

Indacaterol and Mometasone is indicated for:

Asthma

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Indacaterol/mometasone is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short-acting beta2-agonists.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Indacaterol and Mometasone is contraindicated in the following cases:

Lactation

Lactation

Other long-acting betaâ‚‚-adrenergic agonists

β2 (beta2) adrenergic receptor agonists (beta-2-sympathomimetics)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: ATECTURA BREEZHALER Inhalation powder, hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈